CIK 0001756262
- Large accelerated filer
TransMedics Group, Inc.
Sign in to watch- Ticker
- TMDX
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- Phone
- +1 978-552-0900
- Business address
- 200 MINUTEMAN ROAD, ANDOVER, MA, 01810
- Open-market buys, last 90 days
- $109,058
- in 1 filing
- Open-market sales, last 90 days
- $385,464
- in 1 filing
Net −$276,406. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-23 | Khayal Tamer I Chief Commercial Officer | Exercise or conversion | +32,179 | $16.00 | $515K | 46,554 |
| 2023-02-23 | Khayal Tamer I Chief Commercial Officer | Exercise or conversion | +3,751 | $16.14 | $61K | 50,305 |
| 2023-02-23 | Khayal Tamer I Chief Commercial Officer | Sale | −6,319 | $70.18 | $443K | 43,986 |
| 2023-02-23 | Khayal Tamer I Chief Commercial Officer | Sale | −1,763 | $71.46 | $126K | 42,223 |
| 2023-02-23 | Khayal Tamer I Chief Commercial Officer | Sale | −6,218 | $72.02 | $448K | 36,005 |
| 2023-02-23 | Khayal Tamer I Chief Commercial Officer | Sale | −777 | $73.55 | $57K | 35,228 |
| 2023-02-23 | Khayal Tamer I Chief Commercial Officer | Sale | −853 | $74.67 | $64K | 34,375 |
| 2023-02-23 | Khayal Tamer I Chief Commercial Officer | Sale | −20,000 | $75.15 | $1.5M | 14,375 |
| 2023-02-23 | Khayal Tamer I Chief Commercial Officer | Exercise or conversion · Stock Option (Right to Buy) | −32,179 | 8,036 | ||
| 2023-02-23 | Khayal Tamer I Chief Commercial Officer | Exercise or conversion · Stock Option (Right to Buy) | −3,751 | 46,249 | ||
| 2023-02-20 | Provost Miriam VP, Global Regulatory Affairs | Grant or award | +5,685 | 20,839 | ||
| 2023-02-20 | Provost Miriam VP, Global Regulatory Affairs | Grant or award · Stock Option (Right to Buy) | +8,705 | 8,705 | ||
| 2023-02-20 | Khayal Tamer I Chief Commercial Officer | Grant or award | +13,075 | 14,375 | ||
| 2023-02-20 | Khayal Tamer I Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +20,022 | 20,022 | ||
| 2023-02-20 | DAMME LAURA VP, Clinical Affairs | Grant or award | +5,685 | 5,685 | ||
| 2023-02-20 | DAMME LAURA VP, Clinical Affairs | Grant or award · Stock Option (Right to Buy) | +8,705 | 8,705 | ||
| 2023-02-20 | Corcoran Nicholas | Grant or award | +12,886 | 12,886 | ||
| 2023-02-20 | Corcoran Nicholas | Grant or award · Stock Option (Right to Buy) | +19,732 | 19,732 | ||
| 2023-02-20 | Hassanein Waleed H President & CEO | Grant or award | +37,332 | 426,444 | ||
| 2023-02-20 | Hassanein Waleed H President & CEO | Grant or award · Stock Option (Right to Buy) | +57,165 | 57,165 |
Page 28 of 38 · 744 trades